Fierce Biotech August 2, 2024
Johnson & Johnson MedTech has secured an FDA 510(k) clearance for its first robotically guided platform for spine surgery and has slated its commercial launch for the first half of next year.
The DePuy Synthes division’s Velys Spine system is designed to offer what the company describes as active robotic assistance. Instead of using a fixed arm to help steady the placement of a drill, screw or implant, J&J’s approach aims to track and keep pace with any unintentional patient movement—including shifts in the spine itself mid-procedure—as well as adapt to the surgeon’s personal preferences.
“We believe that the unique features and capabilities of active robotics technology will set a new standard in surgical care for spine patients everywhere,” Russell...
Today's Sponsors
Today's Sponsor